70 reports

  • Cystic Fibrosis Products
  • Cystic Fibrosis Products

The market for Cystic Fibrosis Therapeutics is anticipated to grow with double digit CAGR during the forecasting period. Cystic fibrosis is among the most common life-threatening genetic disorders worldwide. It is caused by defects in a single gene known as the cystic fibrosis transmembrane conductance regulator, or CFTR. The increasing...

  • Cystic Fibrosis
  • World
  • Market Size
  • AbbVie Inc.
  • Editas Medicine, Inc.
  • 6 Cystic Fibrosis Market, By Regions
  • GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, 2015 (%)

The global cystic fibrosis market was valued at $ 3145.7 million in 2015 and expected to reach at $ 8852.2 million by 2022 at a CAGR of 13.5 % during the forecast period. The major factors responsible for the growth of global cystic fibrosis market are; development of new drugs and therapies, financial support from interest organizations...

  • Cystic Fibrosis
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated
  • 6 Cystic Fibrosis Market, By Regions
  • 5 Cystic Fibrosis Market, By Treatment Method

Cystic fibrosis is a chronic, genetic disease which affects the productivity of the body leading to severe disability and early death. Symptoms of cystic fibrosis include frequent lung infections, diarrhea, and poor growth of the body. The global cystic fibrosis market is expected to reach USD 8852.2 million by 2022 at a CAGR of 13.5% during...

  • Cystic Fibrosis
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated
  • 2.5.4 CYSTIC FIBROSIS
  • 2.6.4 CYSTIC FIBROSIS

Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers Summary Respiratory disorders, which affect components of the respiratory system such as the...

  • Cystic Fibrosis
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC

Global Cystic Fibrosis Therapeutics Market Outlook 2022 ##.

  • Cystic Fibrosis
  • Therapy
  • World
  • Company Financials
  • Market Size
  • Cystic Fibrosis
  • III. Diagnosis of Cystic Fibrosis

Cystic fibrosis is a rare genetic disorder caused by the mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene located on chromosome 7. It largely affects the lungs and digestive system, and causes the secretions to become thick and sticky. The individuals with cystic fibrosis develop lung disease, resulting...

  • Cystic Fibrosis
  • Therapy
  • World
  • AbbVie Inc.
  • Vertex Pharmaceuticals Incorporated

Global Cystic Fibrosis Therapeutics Market 2016-2026 ##.

  • Cystic Fibrosis
  • Pathology
  • United States
  • World
  • Forecast

Cystic Fibrosis Phase ## Clinical Trials, 2016 ##.

  • Cystic Fibrosis
  • Pathology
  • United States
  • Market Shares
  • Market Size
  • 2 Cystic Fibrosis: Executive Summary
  • CYSTIC FIBROSIS: KEY METRICS IN THE SEVEN MAJOR PHARMACEUTICAL MARKETS

OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2025 Summary Cystic fibrosis (CF), which has been given a the diagnostic code E84 from The International Classification of Diseases, Tenth Edition (ICD-10), is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane...

  • Cystic Fibrosis
  • Forest Laboratories, Inc.
  • Novartis AG
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated
  • EMILY DIMANGO, MD
  • STUART JOSEPH ELBORN, MD

EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2025 Summary Cystic Fibrosis (CF) is an inherited disorder that affects the cells that produce mucus, sweat and digestive juices, and also causes severe damage to the lungs, digestive system and other organs. These secreted fluids are normally thin and slippery....

  • Cystic Fibrosis
  • Canada
  • France
  • Italy
  • Forecast

Global Cystic Fibrosis Epidemiology and Patient Flow Analysis - 2016 ##.

  • Cystic Fibrosis
  • Pathology
  • United States
  • World
  • Forecast

Cystic fibrosis Epidemiology Forecast to 2027 ##.

  • Cystic Fibrosis
  • France
  • Germany
  • Italy
  • Forecast

Cystic Fibrosis (CF) Therapeutics Market Analysis By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration, By Region, And Segment Forecasts, 2014 - 2025 Table of Contents Chapter ##.

  • Cystic Fibrosis
  • Therapy
  • United States
  • Forecast

Drug A: Company ## ##. ##. ##.

  • Cystic Fibrosis
  • Pathology
  • United States
  • Market Shares
  • Snapshot of Cystic Fibrosis
  • 07.5 Manifestations of Cystic Fibrosis

About Cystic Fibrosis Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic...

  • Cystic Fibrosis
  • Europe
  • Actavis plc
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.

Cystic Fibrosis Phase ## Clinical Trials, 2016 ##.

  • Cystic Fibrosis
  • France
  • Germany
  • Market Shares
  • Market Size

Cystic Fibrosis Phase ## Clinical Trials, 2016 ##.

  • Cystic Fibrosis
  • Pathology
  • United States
  • Market Shares
  • Market Size

Cystic Fibrosis Phase ## Clinical Trials, 2016 ##.

  • Cystic Fibrosis
  • Pathology
  • Japan
  • Market Shares
  • Market Size

Cystic Fibrosis Phase ## Clinical Trials, 2016 ##.

  • Cystic Fibrosis
  • Pathology
  • Germany
  • Market Shares
  • Market Size

Cystic Fibrosis Phase ## Clinical Trials, 2016 ##.

  • Cystic Fibrosis
  • Pathology
  • Italy
  • Market Shares
  • Market Size

Cystic Fibrosis Phase ## Clinical Trials, 2016 ##.

  • Cystic Fibrosis
  • Pathology
  • United Kingdom
  • Market Shares
  • Market Size

Cystic Fibrosis Phase ## Clinical Trials, 2016 ##.

  • Cystic Fibrosis
  • Pathology
  • France
  • Market Shares
  • Market Size

Cystic Fibrosis Phase ## Clinical Trials, 2016 ##.

  • Cystic Fibrosis
  • Pathology
  • Spain
  • Market Shares
  • Market Size
  • CYSTIC FIBROSIS
  • CYSTIC FIBROSIS

About Respiratory Ailments Asthma, COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and IPF are some of the major respiratory diseases. Among these, asthma and COPD are the most prevalent worldwide. Environmental pollution, changing lifestyles, and hereditary factors are some of the common causes of respiratory diseases....

  • Cystic Fibrosis
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Carrier Screening Market: Revenue in USD million, by Disease Type, Global, 2018-2023
  • 9.9 AUTOGENOMICS INC.

The global carrier screening market is expected to account for a value of USD 2,237 million, registering a CAGR of about 9.8% during the forecast period (2018-2023). Carrier screening is one of the genetic tests that provide the data on whether a particular person carries a gene for certain genetic disorders or not. When the test is performed...

  • Cystic Fibrosis
  • 23andMe, Inc.
  • Cepheid
  • Illumina, Inc.
  • Sequenom, Inc.
  • CYSTIC FIBROSIS
  • 4.2.3. CYSTIC FIBROSIS

INTRODUCTION According to the Forum of International Respiratory Societies, around 4 million individuals die each year due to chronic respiratory diseases. The World Health Organization (WHO) estimates the global prevalence of two of the most common chronic respiratory diseases, namely asthma and chronic obstructive pulmonary...

  • Cystic Fibrosis
  • North America
  • United States
  • AstraZeneca PLC
  • Novartis AG
  • CYSTIC FIBROSIS MISCELLANEOUS DRUG PIPELINE
  • CYSTIC FIBROSIS DRUG PIPELINE BY COMPANY

Cystic Fibrosis (CF) is a rare genetic disorder caused by a mutation in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene located on chromosome 7. This disorder primarily affects the lungs and digestive system and causes secretions to become thick and sticky. Individuals with Cystic Fibrosis develop lung...

  • Cystic Fibrosis
  • United States
  • World
  • Market Size
  • Vertex Pharmaceuticals Incorporated

(USA) ##.

  • Cystic Fibrosis
  • Erythropoietin
  • China
  • World
  • Market Shares
  • CYSTIC FIBROSIS FOUNDATION THERAPEUTICS ENTERS INTO RESEARCH AGREEMENT WITH PFIZER FOR CYSTIC FIBROSIS DRUGS
  • PROQR THERAPEUTICS ENTERS INTO LICENSING AGREEMENT WITH CYSTIC FIBROSIS FOUNDATION

Summary Cystic Fibrosis Foundation Therapeutics Inc (Cystic), a subsidiary of Cystic Fibrosis Foundation is a healthcare organization that develops treatments for prevention and control of cystic fibrosis.The organization offers CF and school, CFRD, emotional wellness, fitness, lung transplantation, navigating insurance,...

  • Cystic Fibrosis
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

(USA) ##.

  • Cystic Fibrosis
  • China
  • United States
  • World
  • Market Shares